Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
NHS West Yorkshire Integrated Care Board
Scorex House, West 1 Bolton Road
Bradford
BD1 4AS
UK
Contact person: Martin Pursey
E-mail: wyicb-kirk.procurement@nhs.net
NUTS: UKE4
Internet address(es)
Main address: https://www.westyorkshire.icb.nhs.uk/
Address of the buyer profile: https://www.westyorkshire.icb.nhs.uk/
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
NHSWYICB - Non Consultant Led Community Dermatology Service
Reference number: C462784
II.1.2) Main CPV code
85121282
II.1.3) Type of contract
Services
II.1.4) Short description
Non consultant led community dermatology service for the Wakefield population
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
322 869.00
GBP
II.2) Description
II.2.3) Place of performance
NUTS code:
UKE45
II.2.4) Description of the procurement
The Contract Authority; NHS West Yorkshire Integrated Care Board intends to award a contract to an existing provider following Direct Award Process C. The authority is publishing this notice in Find a Tender in accordance with the NHS Provider Selection Regime.<br/><br/>Contract Period: 01/08/2026 - 31/07/2027<br/><br/>Contract Value: £322,869
II.2.5) Award criteria
Quality criterion: The existing provider(s) is satisfying the contract and will likely satisfy the proposed contract to a sufficient standard.
/ Weighting: 100
Cost criterion: The existing provider(s) is satisfying the contract and will likely satisfy the proposed contract to a sufficient standard.
/ Weighting: 0
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
II.2.14) Additional information
1) The ICB is not required to follow direct award process A or B<br/>The Record of Decision Making created at the time of the decision confirms that the service:<br/>• is an existing service;<br/>• is delivered by an existing provider - DMC Healthcare Limited;<br/>• is replacing a contract that is due to expire; and<br/>• is therefore eligible in principle for Direct Award Process C.<br/>The Record also identifies the named decision maker, senior approving bodies, contract value and term, and confirms that no conflicts of interest were declared. This document evidences that the decision was taken consciously and contemporaneously within the PSR framework, rather than by default or assumption.<br/><br/>2) The commissioner confirms that the proposed contracting arrangements are not changing considerably from the existing contract<br/>The Community Dermatology Service Specification dated 01/08/2026 demonstrates that the proposed contract does not introduce any considerable change when compared with the existing arrangements.<br/>In substance:<br/>• the service model remains a community-based integrated pathway;<br/>• the population, geography, referral routes, and eligibility criteria are unchanged;<br/>• delivery remains with the existing provider, using the same delivery and service model;<br/>• there is no expansion, reconfiguration, or transfer of material risk.<br/>The ICB actively reviewed the proposed scope, duration, outcomes, delivery model, and risk profile against the existing contract and concluded that none of these elements met the PSR “considerable change” threshold. While the specification is presented in an updated format, the underlying service is materially consistent with the existing contract.<br/>The financial value of the contract award is within the material change threshold. The nature of the service being delivered remains materially unchanged. <br/><br/>As previously indicated, there are no changes are proposed to the service specification, referral criteria, population served, service geography, contractual outcomes or delivery model<br/><br/>3) The ICB is of the view that the existing provider is satisfying the existing contract to a sufficient standard, according to the detail outlined in the contract, and also taking into account the key criteria and applying the basic selection criteria<br/>The Service Review Template – PSR Key Criteria provides detailed, narrative based evidence demonstrating that the existing provider:<br/>• is satisfying the current contract to a sufficient standard; and<br/>• is likely to satisfy the proposed contract to a sufficient standard.<br/>The service specification, patient cohort, geography, referral routes, contractual outcomes and delivery model remain unchanged. The proposed contract value remains within the material change threshold and reflects the current level of activity delivered by the provider. The commissioner is satisfied that there has been no considerable change to the contracting arrangements.<br/>The Service Review assesses performance against all PSR key criteria, including:<br/>• Quality and innovation – supported by/evidenced by commissioner evaluation of outcomes, policies and procedures against expected standards and KPI’s and peer benchmarking. <br/>• Value and stewardship of public funds – demonstrated through cost effectiveness, system savings, sustainability.<br/>• Integration, collaboration, and sustainability – evidenced through partnership working, alignment with wider pathways, digital interpolation and investment.<br/>• Access, inequalities, and choice – supported by evidence of targeted interventions, inclusive or adapted provision, reach into underserved or priority populations.<br/>• Social value – including evaluation of local employment and staff wellbeing community capacity building, wider economic or social benefits.<br/>The ICB considered not only historic performance, but also whether the provider’s established workforce, governance arrangements, and delivery model provide assurance of continued performance under the proposed contract. The proposed contract does not introduce new delivery requirements, expanded cohorts, or increased demand beyond that already successfully managed by the provider.<br/>4) Proportionality and Overall Assurance<br/>In determining the appropriate procurement route, the ICB considered whether a competitive process would deliver additional benefit. Given the continuity of need, the absence of material change, the provider’s sustained performance, and the risks associated with service disruption, the ICB concluded that a competitive process would not be proportionate to the time, cost, and delivery risk involved.<br/>Taken together, the three documents; Record of Decision Making, Service Specification and Service Review Template provide a coherent and auditable justification for the use of Direct Award Process C, demonstrating that:<br/>• the regulatory conditions for Process C are met;<br/>• the decision was taken lawfully, transparently, and proportionately;<br/>• the existing provider sufficiently meets the PSR criteria; and<br/>• continuity of a clinically effective and system beneficial service is in the best interests of patients and the wider system.<br/>WY ICB therefore remains satisfied that the requirements of the Provider Selection Regime have been properly applied and evidenced.<br/><br/>• The procurement is not to conclude a framework agreement or to award a contract based on a framework agreement
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
New works/services, constituting a repetition of existing works/services and ordered in accordance with the strict conditions stated in the Directive
Explanation
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the Standstill Period. Representations by providers must be made to the relevant authority by 1 September 2026. This contract has not yet formally been awarded; this notice serves as an intention to award a contract under the PSR.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
Section V: Award of contract
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
10/08/2026
V.2.2) Information about tenders
Number of tenders received: 1
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
DMC Healthcare Limited
06745192
60 Chadwick Road, Peckham
London
SE15 4PU
UK
NUTS: UKI
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 322 869.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The publication of this notice marks the start of the Standstill Period. Representations by providers must be made to the relevant authority by 1 September 2026. This contract has not yet formally been awarded; this notice serves as an intention to award a contract under the PSR.<br/><br/>Written representations should be sent to wyicb-kirk.procurement@nhs.net<br/><br/><br/>Proportionality and Overall Assurance<br/>In determining the appropriate procurement route, the ICB considered whether a competitive process would deliver additional benefit. Given the continuity of need, the absence of material change, the provider’s sustained performance, and the risks associated with service disruption, the ICB concluded that a competitive process would not be proportionate to the time, cost, and delivery risk involved.<br/>Taken together, the three documents; Record of Decision Making, Service Specification and Service Review Template provide a coherent and auditable justification for the use of Direct Award Process C, demonstrating that:<br/>• the regulatory conditions for Process C are met;<br/>• the decision was taken lawfully, transparently, and proportionately;<br/>• the existing provider sufficiently meets the PSR criteria; and<br/>• continuity of a clinically effective and system beneficial service is in the best interests of patients and the wider system.<br/>WY ICB therefore remains satisfied that the requirements of the Provider Selection Regime have been properly applied and evidenced.<br/>The service was evaluated against the PSR Key Criteria (weighted equally) using narrative based evidence service review.<br/><br/>No Conflict of Interest raised<br/><br/>Approver: Wakefield Place Management Team & Director of Partner Relationship Management
VI.4) Procedures for review
VI.4.1) Review body
WYICB PSR Review Panel
Scorex House, West 1 Bolton Road
Bradford
BD1 4AS
UK
Internet address(es)
URL: https://www.westyorkshire.icb.nhs.uk/
VI.4.2) Body responsible for mediation procedures
NHS England Independent Patient Choice and Procurement Panel
London
London
SE1 8UG
UK
Internet address(es)
URL: https://www.england.nhs.uk/commissioning/how-commissioning-is-changing/nhs-provider-selection-regime/independent-patient-choice-and-procurement-panel/
VI.4.4) Service from which information about the review procedure may be obtained
NHS West Yorkshire Integrated Care Board
Scorex House, West 1 Bolton Road
Bradford
BD1 4AS
UK
Internet address(es)
URL: https://www.westyorkshire.icb.nhs.uk/
VI.5) Date of dispatch of this notice
20/08/2026